Description
BSE announces the upcoming listing and admission to dealings of equity shares of Nephrocare Health Services Limited with scrip code 544647 and symbol NEPHROPLUS.
Summary
BSE has announced that equity shares of Nephrocare Health Services Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544647 and trading symbol NEPHROPLUS with ISIN number INE428V01029. The specific date of listing and details of the securities will be communicated through a separate notice.
Key Points
- Company Name: Nephrocare Health Services Limited
- Scrip Code: 544647
- Trading Symbol: NEPHROPLUS
- ISIN Number: INE428V01029
- Listing date to be announced separately
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE Limited
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members of the Exchange are informed to note the upcoming listing of Nephrocare Health Services Limited equity shares for future trading activities.
Important Dates
- Notice Date: December 16, 2025
- Listing Date: To be informed through separate notice
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. Trading members should note the new scrip details for preparation once the actual listing date is announced. The listing will add one more equity security to BSE’s trading platform in the healthcare services sector.
Impact Justification
Standard new listing announcement with limited immediate market impact. Specific listing date to be notified separately.